Target intelligence / Profile preview

Rhophilin-associated tail protein 1B (ROPN1B)

Target
ROPN1B
Molecular classification
Other (adaptors and sperm-specific binding proteins), Cancer-testis antigen (biomarker family)
01

Overview

Rhophilin-associated tail protein 1B (ROPN1B) is a testis-enriched, cytoplasmic protein that functions as an adaptor, predominantly found in the fibrous sheath of spermatozoa, and binds to A-kinase anchoring proteins such as AKAP110 to participate in PKA-dependent signaling processes essential for sperm motility and capacitation[5][8]. ROPN1B has 96% sequence homology with its paralog ROPN1A and is widely expressed as a cancer-testis antigen in several tumor types, notably melanoma, breast cancer, and hematological malignancies[2]. Its expression in tumors, particularly melanoma (with 88.5% of patient samples positive), is linked to poor prognosis and metastasis, possibly through RhoA signaling pathway activation[2]. ROPN1B’s role as a tumor antigen and its immunogenicity in cancer patients make it a promising subject for immunotherapy research, though no approved drugs currently target this molecule, and fertility concerns must be managed if considered for clinical targeting[2][5][8][1].

Other names
Ropporin-1BRhophilin-associated protein 1Bropporin-1BAKAP-binding sperm protein ropporinropporintestis tissue sperm-binding protein Li 83P
02

Biological functions

Sperm motility (fibrous sheath integrity, flagellated sperm motility)PKA-dependent signaling (A-kinase anchoring protein binding)Protein binding within signaling complexes (adaptor role)Sperm capacitation (preparation of sperm for fertilization)
03

Disease associations

Male infertility/subfertility (mutations linked to spermatogenic failure)Cancer (testis antigen): melanoma, breast cancer, multiple myeloma, hematologic malignanciesOther: marker in varicocele
04

Safety considerations

Tumor antigen therapies may risk autoimmune reactions in normal tissues where ROPN1B is expressed (primarily testis)Possible off-tumor activity in fertility due to natural testis expression
05

Biomarkers

Cancer-testis antigen in melanoma, multiple myeloma, and other cancers—enables patient selection for immunotherapy trialsImmunogenic protein used in research for patient stratification (antibodies against ROPN1B indicate immune response in cancer)

Beyond the preview

Go deeper on Rhophilin-associated tail protein 1B (ROPN1B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rhophilin-associated tail protein 1B (ROPN1B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call